Healio Psoriatic Disease Current Issue
The following articles appeared in the print edition of Healio Psoriatic Disease.
Table of Contents
- Treating psoriasis inflammation can reduce cardiovascular risks Rebecca L. Forand
-
- What is topical in psoriasis? Joel M. Gelfand, MD, MSCE
- European Commission expands approved indications for subcutaneous infliximab biosimilar Robert Stott
- FDA approves Tremfya, first IL-23 inhibitor for psoriatic arthritis Robert Stott
- FDA approves Wynzora cream for plaque psoriasis
- Q&A: Psoriasis Awareness Month a time to educate, learn Rebecca L. Forand
- Q&A: Treating psoriasis in pediatric patients Rebecca L. Forand
- Generic drug substitution laws vary greatly across US Janel Miller
- Roflumilast cream superior to vehicle in treatment of plaque psoriasis Kate Burba
-
- Tape strips identify biomarkers for atopic dermatitis, psoriasis Rebecca L. Forand
- Better resolution of nail psoriasis seen with ixekizumab than adalimumab Rebecca L. Forand
- ‘Heavier workload’ in autoimmune care amid COVID-19 begs for interdisciplinary teamwork Rob Volansky
- Long-term tildrakizumab beneficial in treating plaque psoriasis Rebecca L. Forand
- Patients increasingly turn to social media for dermatologic diagnoses, treatment advice Rebecca L. Forand
- Bimekizumab shows positive phase 3b results against Cosentyx
- Stelara approved for pediatric plaque psoriasis